Category: Treatment
Long Covid fatigue caused by an Arginine deficiency
The mechanism that leads to chronic fatigue in Long Covid patients has been discovered, according to new Italian research.… ...More...
Sato Lab: Virological characteristics of XBB.1.5
Japan’s Sato Lab have announced new research into the Omicron XBB.1.5 ‘Kraken’ variant, confirming much about what is already known or suspected about its transmissibility.… ...More...
It’s Britain’s third-largest Covid wave ever, and it’s still climbing…
New figures out today from UK Covid app ZOE show there are currently 3,092,451 symptomatic cases of Covid-19 in Britain, making it the third-largest Covid wave ever, and the wave is still growing.… ...More...
Research: 14.6% Paxlovid contraindication rate for hospitalized patients with Covid-19
“We examined the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19.… ...More...
Singapore: XBB variant more prevalent in those without a previous Covid infection
Singapore’s Health Minister, Ong Ye Kung, has said that he expects the current XBB SARS-CoV-2 wave to peak in mid-November 2022. … ...More...
XBB set to become the dominant variant in Singapore
XBB is set to become the dominant variant in Singapore, and is already dominant in Bangladesh.… ...More...
WHO: 63 confirmed and probable Ebola cases, 29 deaths in Uganda
“So far, 63 confirmed and probable [Ebola] cases have been reported, including 29 deaths.… ...More...
Multiple hypermutated SARS-CoV-2 sequences that may have been created by molnupiravir
Molnupiravir, a drug used to treat SARS-CoV-2 infections, has received a lot of press attention since its launch, and not all of it has been positive.… ...More...
Growth advantage for BQ.1.1 is above 100% per week
The Omicron variant BQ.1.1 appears to be in a prime position to drive the coming winter wave in Europe.… ...More...
Preprint: Mutated SARS-CoV-2 variant resistant to remdesivir
A new preprint study shows that two kidney transplant patients treated with immunosuppressive drugs, and who later had a lengthy COVID-19 infection, developed a version of the virus with a genetic change that made it resistant to the antiviral therapy remdesivir.… ...More...